Sequential CTC enumeration during treatment can supplement standard medical tests to unveil whether patients with locally advanced or metastatic HCC, particularly for the AFP-low cases, have a stable disease, partial response, or disease progression [25]. The gene discussed is AFP; the disease is hepatocellular carcinoma.